Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

April 2013 Onwards
Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Important Regulator of Immune System Decoded
Plasma cells play a key role in our immune system. Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function.
Bacterial Superglue for Faster Vaccine Development
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.
Enumeral, MD Anderson Enter Into Collaboration
Strategic collaboration aims to discover and develop potentially novel antibodies against specified targets for immunotherapy.
Joint venture for GlycoMar Limited and MicroA AS
Scottish biotechnology company GlycoMar and Norwegian technology company MicroA are pleased to announce their joint venture business Prasinotech Ltd. The new company is registered in Scotland.
19 Mar 2013 - 11 Apr 2013
Live-on-the-web
Peptide and Protein Characterization with LC/MS
More information
3rd Annual Pharma Logistics & Cold Chain Forum
09 Apr 2013 - 10 Apr 2013
Vienna, Austria
3rd Annual Pharma Logistics & Cold Chain Forum
More information
ADME & Predictive Toxicology
11 Apr 2013 - 12 Apr 2013
Barcelona, Spain
ADME & Predictive Toxicology
More information
Biologics World Korea 2013
16 Apr 2013 - 18 Apr 2013
Seoul, South Korea
Biologics World Korea 2013
More information
World Vaccine Congress & Expo Washington 2013
16 Apr 2013 - 18 Apr 2013
Washington DC, USA
World Vaccine Congress & Expo Washington 2013
More information
16 Apr 2013 - 18 Apr 2013
PA, USA
12th Measuring and Optimizing MSL Practices
More information
17 Apr 2013 - 18 Apr 2013
Dusseldorf
Production Strategies for Biosimilars, ADCs and non-mAbs
More information
17 Apr 2013 - 18 Apr 2013
Dusseldorf
Upstream Processing and Cell Culture
More information
17 Apr 2013 - 18 Apr 2013
Dusseldorf
Downstream Processing: Capture, Recovery and Purification
More information
<< 1 2 3 4 5 6 7 >>
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!